Sunday, October 4, 2015

Philly drugmaker raises $75M

Iroko in deal with OrbiMed to invest in Zorvolex painkiller

Philly drugmaker raises $75M


Iroko Pharmaceuticals LLC, the pain-control drugmaker whose new glass-walled U.S. headquarters is at the old Navy Yard in South Philadelphia, says it's agreed to borrow up to $75 million from OrbiMed Advisors LLC "to support general business operations and the launch of Zorvolex," the fast-dissolving, newly FDA-approved painkiller also known as diclofenac, so it can go on the market in early 2014.

New York-based OrbiMed says it specializes in funding drug development as a "long-term partner" for smaller and specialized companies like Iroko. The OrbiMed line of credit will help Iroko boost sales of its new product, Iroko executive board chairman Osagie Imasogie said in a statement.

We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog

PhillyDeals posts drafts, transcripts and updates of Joseph N. DiStefano's columns and stories about Philly-area business, which he's been writing since 1989.

DiStefano studied economics, history and a little engineering at Penn and taught writing at St. Joseph's. He has written thousands of columns and articles for the Inquirer, Bloomberg and other media, wrote the book Comcasted, and raised six children with his wife, who is a saint.

Reach Joseph N. at,, 215.854.5194 or 302.652.2004.

Reach Joseph N. at or 215 854 5194.

Joseph N. DiStefano
Also on
letter icon Newsletter